Indo US Bio-Tech (NSE:INDOUS) Margin of Safety % (DCF Earnings Based): 43.07% (As of Jun. 26, 2026)


NSE:INDOUS Indo US Bio-Tech Ltd NSE:INDOUS
63 GF Score
Price ₹88.75
GF Value ₹198.40
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Indo US Bio-Tech Margin of Safety % (DCF Earnings Based)?

Indo US Bio-Tech NSE:INDOUS -0.27% 63 Margin of Safety % (DCF Earnings Based) is 43.07% as of Jun. 26, 2026. GuruFocus rates NSE:INDOUS with a GF Score™ of 63/100 and a GF Value™ of ₹198.40 (Possible Value Trap). The stock has 5 warning signs investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-06-26), Indo US Bio-Tech's Predictability Rank is 3.5-Stars. Indo US Bio-Tech's intrinsic value calculated from the Discounted Earnings model is ₹155.90 and current share price is ₹88.75. Consequently,

Indo US Bio-Tech's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is 43.07%.

NSE:INDOUS vs CTVA, CF: Margin of Safety % (DCF Earnings Based) Comparison

For the Agricultural Inputs subindustry, Indo US Bio-Tech's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indo US Bio-Tech Margin of Safety % (DCF Earnings Based) vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's Margin of Safety % (DCF Earnings Based) falls into.


NSE:INDOUS
63GF Score
Indo US Bio-Tech Ltd NSE:INDOUS
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo US Bio-Tech Margin of Safety % (DCF Earnings Based) Calculation

Indo US Bio-Tech's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(155.90-88.75)/155.90
=43.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of 43.07% mean?
Indo US Bio-Tech (NSE:INDOUS) has a Margin of Safety % (DCF Earnings Based) of 43.07% as of Jun. 26, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Indo US Bio-Tech.
Is Indo US Bio-Tech's Margin of Safety % (DCF Earnings Based) too high?
Indo US Bio-Tech's current Margin of Safety % (DCF Earnings Based) is 43.07%. Overall, Indo US Bio-Tech has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's Margin of Safety % (DCF Earnings Based) compare to CTVA and CF?
Indo US Bio-Tech's Margin of Safety % (DCF Earnings Based) of 43.07% can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for an Agriculture company?
A good Margin of Safety % (DCF Earnings Based) depends on the Agriculture industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Indo US Bio-Tech. Indo US Bio-Tech's current Margin of Safety % (DCF Earnings Based) is 43.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹198.40, compared to a current price of ₹88.75 — trading 55.3% below its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is 43.07%. Indo US Bio-Tech's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current Margin of Safety % (DCF Earnings Based) is 43.07% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?

Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued. The current stock price of ₹88.75 is trading 55.3% below its estimated GF Value™ of ₹198.40. GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.

Key valuation signals for NSE:INDOUS:

  • Margin of Safety % (DCF Earnings Based): 43.07%
  • GF Value™: ₹198.40 vs. price of ₹88.75 (55.3% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indo US Bio-Tech Business Description

Other Exchanges 541304:India
Address Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
63GF Score

Get the complete analysis for NSE:INDOUS

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹88.75
Price
₹198.40
GF Value